Atropos Health vs Vera Health (2026)
Both answer a clinical question and they reach for different evidence when the literature runs out. Vera Health searches what has been published, retrieval first by design over a very large corpus with evidence grading applied before anything is generated, free to verified clinicians, and it publishes the full text of its business associate agreement, which is the strongest contracting posture in this segment. Atropos starts where that ends, generating a publication grade observational study from a federated network of de identified records to answer the question no trial has addressed, with records linked only at query time rather than pooled. The honest sequence is Vera first and Atropos when you already know the literature is silent. Vera's own performance claims are all vendor generated, and Atropos publishes no price, no attestation and no trust centre, so both carry real diligence burdens.
- It generates evidence that does not exist yet, running an observational study across a federated network of de identified records to answer the question no published trial covers.
- The privacy architecture is the disclosure: records are linked only at query time rather than pooled into a warehouse, which removes the aggregation risk instead of governing it.
- The output is a study with an inspectable method rather than a summary, so the result can be argued with, defended in a committee or submitted.
- The business associate agreement is published in full at a public address and dated, which is the strongest posture on that axis in this segment and readable before any sales conversation.
- The architecture is retrieval first by design, searching a very large corpus of peer reviewed papers, guidelines and care pathways and grading evidence before generating rather than generating and then citing.
- It is free to verified clinicians and trainees with unlimited searches, and states plainly that personal data is not used to train its models.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Atropos Health and Vera Health are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Atropos Health | Vera Health |
|---|---|---|
| Primary category | Clinical Reference & Evidence | Clinical Reference & Evidence |
| Founded | 2020 | Not recorded |
| Headquarters | Palo Alto, California | San Francisco, California |
| Website | atroposhealth.com | verahealth.ai |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Atropos Health its top capability grade on several axes, including AI Centrality, Autonomy and Oversight Model and Model and Technology Transparency. Set against Vera Health, Atropos Health grades higher on several axes, including Autonomy and Oversight Model, Model and Technology Transparency and Model Supply Chain Disclosure. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Vera Health its top capability grade on AI Centrality and HIPAA and BAA Posture. Set against Atropos Health, Vera Health grades higher on HIPAA and BAA Posture, Security Certifications and Trust Center and Commercial Transparency. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Atropos Health or Vera Health?
On the axes where the AI Health Index separates them, Atropos Health grades higher on several axes, including Autonomy and Oversight Model, Model and Technology Transparency and Model Supply Chain Disclosure, and Vera Health grades higher on HIPAA and BAA Posture, Security Certifications and Trust Center and Commercial Transparency. Atropos Health leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Atropos Health and Vera Health differ most?
The widest separation the AI Health Index records between Atropos Health and Vera Health is on Model Supply Chain Disclosure, where Atropos Health grades A and Vera Health grades C. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do Atropos Health and Vera Health grade the same?
The AI Health Index grades Atropos Health and Vera Health the same on several axes, including AI Centrality, FDA and Regulatory Status and AI Governance and Bias Disclosure. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Decision Support page.
These products are sequential rather than competing: one retrieves what has been published, the other generates new observational evidence when nothing has. Every performance figure Vera Health publishes is vendor generated and none is peer reviewed, including examination style benchmark scores that describe examination performance rather than bedside answer quality. Atropos publishes no pricing of any kind, no security attestation and no trust centre.
Observational evidence produced on demand carries confounding and selection risks that speed does not remove, so the methodology of each generated study is what should be reviewed rather than the turnaround time.